Clinical Expertise
About Dr. Flanigan
Interests
Medical Education
Medical School
Case Western Reserve University School of MedicineResidency
University Hospitals of Cleveland/Case Western Reserve University - UrologyFellowship
Board Certification
American Board of Urology
Research
- Cytoreductive Nephrectomy for Synchronous Metastatic Renal Cell Carcinoma: Are There Any Favorable Risk Patients? Patel, HD; Clark, JI; Flanigan, RC, The Journal of urology
- Re: Active Surveillance for Men with Intermediate Risk Prostate Cancer. Koehne, EL; Flanigan, RC, European urology
- Patient and physician reported toxicity with two-fraction definitive high-dose-rate prostate brachytherapy: the impact of implant interval. Harris, AA; Korpics, M; Sherwani, Z; Farooq, A; Baldea, KG; Flanigan, R; Harkenrider, MM; Solanki, AA, Journal of contemporary brachytherapy
- Lipofuscin pigmentation (so called "melanosis") of the bladder. Atieh, M; McIntire, PJ; Kilic, I; Picken, MM; Flanigan, RC; Barkan, GA; Pambuccian, SE, Diagnostic cytopathology
- Pre-diagnostic carbohydrate intake and treatment failure after radical prostatectomy for early-stage prostate cancer. Kim, K; Kong, A; Flanigan, RC; Quek, ML; Hollowell, CMP; Vidal, PP; Branch, J; Dean, LA; Macias, V; Kajadacsy-Balla, AA; Fitzgibbon, ML; Cintron, D; Liu, L; Freeman, VL, Cancer causes & control : CCC
- Re: Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. Flanigan, RC, European urology
- Socioeconomic Disparities in the Acute Management of Stone Disease in the United States. Kirshenbaum, EJ; Doshi, C; Dornbier, R; Blackwell, RH; Bajic, P; Gupta, GN; Gorbonos, A; Turk, TMT; Flanigan, RC; Baldea, KG, Journal of Endourology
- Adhesive Bowel Obstruction Following Urologic Surgery: Improved Outcomes with Early Intervention. Blackwell, RH; Kothari, AN; Shah, A; Gang, W; Quek, ML; Luchette, FA; Flanigan, RC; Kuo, PC; Gupta, GN, Current urology
- Diversity of the midstream urine microbiome in adults with chronic kidney disease. Kramer, H; Kuffel, G; Thomas-White, K; Wolfe, AJ; Vellanki, K; Leehey, DJ; Bansal, VK; Brubaker, L; Flanigan, R; Koval, J; Wadhwa, A; Zilliox, MJ, International Urology and Nephrology
- Implications of postoperative pulmonary aspiration following major urologic surgery Kirshenbaum, E. J.; Blackwell, R. H.; Li, B.; Kothari, A. N.; Kuo, P. C.; Flanigan, R. C.; Gorbonos, A.; Gupta, G. N., The Canadian journal of urology
- Sunitinib and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma. Bajic, P; Joyce, CJ; Flanigan, RC, The Journal of urology
- The LACE Score as a Tool to Identify Radical Cystectomy Patients at Increased Risk of 90-Day Readmission and Mortality. Saluk, JL; Blackwell, RH; Gange, WS; Zapf, MAC; Kothari, AN; Kuo, PC; Quek, ML; Flanigan, RC; Gupta, GN, Current urology
- Thirty-day hospital revisits after prostate brachytherapy: who is at risk? Li, B; Kirshenbaum, EJ; Blackwell, RH; Gange, WS; Saluk, J; Zapf, MAC; Kothari, AN; Flanigan, RC; Gupta, GN, Prostate international
- Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions. Solanki, AA; Mysz, ML; Patel, R; Surucu, M; Kang, H; Plypoo, A; Bajaj, A; Korpics, M; Martin, B; Hentz, C; Gupta, G; Farooq, A; Baldea, KG; Pawlowski, J; Roeske, J; Flanigan, R; Small, W; Harkenrider, MM, Advances in radiation oncology
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6 630 Men, Catalona, W. J.; Richie, J. P.; Ahmann, F. R.; Hudson, M. A.; Scardino, P. T.; Flanigan, R. C.; DeKernion, J. B.; Ratliff, T. L.; Kavoussi, L. R.; Dalkin, B. L.; Waters, W. B.; MacFarlane, M. T.; Southwick, P. C., The Journal of urology
- Incidence of Adverse Contrast Reaction Following Nonintravenous Urinary Tract Imaging Blackwell, R. H.; Kirshenbaum, E. J.; Zapf, M. A. C.; Kothari, A. N.; Kuo, P. C.; Flanigan, R. C.; Gupta, G. N., European urology focus
- Early Intervention during Acute Stone Admissions: Revealing "The Weekend Effect" in Urological Practice Blackwell, R. H.; Barton, G. J.; Kothari, A. N.; Zapf, M. A.; Flanigan, R. C.; Kuo, P. C.; Gupta, G. N., The Journal of urology
- PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes Greco, K. A.; Franzen, C. A.; Foreman, K. E.; Flanigan, R. C.; Kuo, P. C.; Gupta, G. N., Urology
- Urinary incontinence and diuretic avoidance among adults with chronic kidney disease Patel, M.; Vellanki, K.; Leehey, D. J.; Bansal, V. K.; Brubaker, L.; Flanigan, R.; Koval, J.; Wadhwa, A.; Balasubramanian, N.; Sandhu, J.; Kramer, H., International Urology and Nephrology
- A primer on clinical trial design Ellimoottil, C.; Vijan, S.; Flanigan, R. C., Urologic oncology
- New Onset Postoperative Atrial Fibrillation Predicts Long-Term Cardiovascular Events Following Radical Cystectomy Blackwell, R. H.; Ellimoottil, C.; Bajic, P.; Kothari, A.; Zapf, M.; Kliethermes, S.; Flanigan, R. C.; Quek, M. L.; Kuo, P. C.; Gupta, G. N., The Journal of urology
- Urinary Exosomes: The Potential for Biomarker Utility Intercellular Signaling and Therapeutics in Urological Malignancy, Franzen, C. A.; Blackwell, R. H.; Foreman, K. E.; Kuo, P. C.; Flanigan, R. C.; Gupta, G. N., The Journal of urology
- Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes Franzen, C. A.; Blackwell, R. H.; Todorovic, V.; Greco, K. A.; Foreman, K. E.; Flanigan, R. C.; Kuo, P. C.; Gupta, G. N., Oncogenesis
- New modalities for evaluation and surveillance of complex renal cysts Ellimoottil, C.; Greco, K. A.; Hart, S.; Patel, T.; Sheikh, M. M.; Turk, T. M.; Flanigan, R. C., The Journal of urology
- Seeking a standard for adequate pathologic lymph node staging in primary bladder carcinoma Wang, L.; Mudaliar, K.; Mehta, V.; Barkan, G. A.; Quek, M. L.; Flanigan, R. C.; Picken, M. M., Virchows Archiv : an international journal of pathology
- Acute acalculous cholecystitis after radical cystectomy: a report of two cases Greco, K. A.; Flanigan, R. C.; Quek, M. L., International journal of urology : official journal of the Japanese Urological Association
- An Analysis of Leukapheresis and central venous catheter use in the randomized placebo controlled, phase 3 IMPACT trial of Sipuleucel-T for metastatic castrate resistant prostate cancer, Flanigan, R. C.; Polcari, A. J.; Shore, N. D.; Price, T. H.; Sims, R. B.; Maher, J. C.; Whitmore, J. B.; Corman, J. M., The Journal of urology
- How to prepare and present scientific manuscripts in English Hannick, J. H.; Flanigan, R. C., International journal of urology : official journal of the Japanese Urological Association
- Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer Rao, M. V.; Ellimoottil, C.; Sondej, T.; Flanigan, R. C.; Quek, M. L., Urologic oncology
- Legends in urology Flanigan, R. C., The Canadian journal of urology
- Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy Rao, M. V.; Quek, M. L.; Jayram, G.; Ellimoottil, C.; Sondej, T.; Hugen, C. M.; Flanigan, R. C.; Steinberg, G. D., ISRN urology
- Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat Mehta, V.; Mudaliar, K.; Ghai, R.; Quek, M. L.; Milner, J.; Flanigan, R. C.; Picken, M. M., Archives of Pathology & Laboratory Medicine
- Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6 Mehta, V.; Rycyna, K.; Baesens, B. M.; Barkan, G. A.; Paner, G. P.; Flanigan, R. C.; Wojcik, E. M.; Venkataraman, G., INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
- Prognostic variables and nomograms for renal cell carcinoma Flanigan, R. C.; Polcari, A. J.; Hugen, C. M., International Journal of Urology
- Vanishing prostate cancer on radical prostatectomy (RP) in the PSA era: incidence and follow-up data from a cohort of 1 060 patients between 1998 and 2010, Mehta, V.; Mehrotra, S.; Flanigan, R. C.; Wojcik, E. M.; Venkataraman, G., Virchows Archiv : an international journal of pathology
- Long-term outcomes of salvage radiotherapy for PSA-recurrent prostate cancer: validation of the Stephenson nomogram. Hugen, C. M.; Polcari, A. J.; Quek, M. L.; Garza, R. P.; Fitzgerald, M. P.; Flanigan, R. C., World journal of urology
- Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer. Hugen, C. M.; Polcari, A. J.; Fitzgerald, M. P.; Dauw, C.; Flanigan, R. C.; Quek, M. L., Journal of surgical oncology
- The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. Mulhall, J. P.; Parker, M.; Waters, B. W.; Flanigan, R. C., BJU international
- Comparison of open and robot-assisted pelvic lymphadenectomy for prostate cancer. Polcari, A. J.; Hugen, C. M.; Sivarajan, G.; Woods, M. E.; Paner, G. P.; Flanigan, R. C.; Quek, M. L., Journal of Endourology
- Morphometric signature differences in nuclei of Gleason pattern 4 areas in Gleason 7 prostate cancer with differing primary grades on needle biopsy. Venkataraman, G.; Rycyna, K.; Rabanser, A.; Heinze, G.; Baesens, B. M.; Ananthanarayanan, V.; Paner, G. P.; Barkan, G. A.; Flanigan, R. C.; Wojcik, E. M., Journal of Urology
- Penile rehabilitation following radical prostatectomy: predicting success Muller, A.; Parker, M.; Waters, B. W.; Flanigan, R. C.; Mulhall, J. P., The journal of sexual medicine
- Persistent erectile dysfunction following radical prostatectomy: the association between nerve-sparing status and the prevalence and chronology of venous leak. Tal, R.; Valenzuela, R.; Aviv, N.; Parker, M.; Waters, W. B.; Flanigan, R. C.; Mulhall, J. P., Journal of Sexual Medicine
- Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949. Lara, P. N., Jr; Tangen, C. M.; Conlon, S. J.; Flanigan, R. C.; Crawford, E. D., Journal of Urology
- Renal FNA-based typing of renal masses remains a useful adjunctive modality: evaluation of 31 renal masses with correlative histology. Masoom, S.; Venkataraman, G.; Jensen, J.; Flanigan, R. C.; Wojcik, E. M., Cytopathology
- The role of cytoreductive nephrectomy in the era of molecular targeted therapy Polcari, A. J.; Gorbonos, A.; Milner, J. E.; Flanigan, R. C., International Journal of Urology
- The role of lymph node density in bladder cancer prognostication Quek, M. L.; Flanigan, R. C., World journal of urology
- Words of wisdom. Re: Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. Flanigan, R. C.; Polcari, A., European urology
- An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre open-label, randomised phase III trial., Wood, C.; Srivastava, P.; Bukowski, R.; Lacombe, L.; Gorelov, A. I.; Gorelov, S.; Mulders, P.; Zielinski, H.; Hoos, A.; Teofilovici, F.; Isakov, L.; Flanigan, R. C.; Figlin, R.; Gupta, R.; Escudier, B., Lancet
- Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies: correlation with conventional cytogenetics and fluorescence in situ hybridization. Picken, M. M.; Chyna, B.; Flanigan, R. C.; Lee, J. M., American Journal of Clinical Pathology
- Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas. Meyer, P. N.; Cao, Y.; Jacobson, K.; Krausz, T.; Flanigan, R. C.; Picken, M. M., Diagnostic Molecular Pathology
- High incidence of aneuploidy in low grade urothelial carcinomas Alvarez, A.; Venkataraman, G.; Quek, M.; Flanigan, R.; Wojcik, E., International Journal of Urology
- Maintenance of Certification: what is it and why is it happening. Flanigan, R. C.; Howards, S. S., AUA Update Series
- Prostate specific antigen (PSA)-based screening. Suzuki, H.; Flanigan, R. C.; Okuyama, A., International Journal of Urology
- Renal cell carcinoma in two patients with crossed fused ectopic kidneys. Davis, C. M.; Rao, M. V.; Flanigan, R. C.; Quek, M. L., Urologia internationalis
- The importance of histology and cytogenetics in decision making for renal cell carcinoma. Garcia, J. G.; Picken, M. M.; Flanigan, R. C., World journal of urology
- Urine cytology for surveillance of the remnant urothelium after radical cystectomy and urinary diversion Fok, C. S.; Liu, L.; Venkataraman, G.; Barkan, G. A.; Flanigan, R. C.; Wojcik, E. M.; Quek, M. L., Journal of Urology
- High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies. Paner, G. P.; Lindgren, V.; Jacobson, K.; Harrison, K.; Cao, Y.; Campbell, S. C.; Flanigan, R. C.; Picken, M. M., Archives of Pathology & Laboratory Medicine
- Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer. Venkataraman, G.; Heinze, G.; Holmes, E. W.; Ananthanarayanan, V.; Bostwick, D. G.; Paner, G. P.; Bradford-De La garza, C. M.; Brown, H. G.; Flanigan, R. C.; Wojcik, E. M., Prostate
- Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer. Nagda, S. N.; Mohideen, N.; Lo, S. S.; Khan, U.; Dillehay, G.; Wagner, R.; Campbell, S.; Flanigan, R. C., International journal of radiation oncology, biology, physics
- Prostatic fatty acids and cancer recurrence after radical prostatectomy for early-stage prostate cancer. Freeman, V. L.; Flanigan, R. C.; Meydani, M., Cancer Causes & Control
- Renal tumors: the good the bad, and the ugly, Flanigan, R. C., International Journal of Urology
- Self-reported volume of radical prostatectomies among urologists in the USA. Denberg, T. D.; Flanigan, R. C.; Kim, F. J.; Hoffman, R. M.; Steiner, J. F., BJU international
- The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer. Kositsawat, J.; Flanigan, R. C.; Meydani, M.; Choi, Y. K.; Freeman, V. L., Journal of Urology
- Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method. Kapur, U.; Antic, T.; Venkataraman, G.; Durazo-Arvizu, R. A.; Quek, M. M.; Flanigan, R. C.; Wojcik, E. M., Urology
- Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Meyer, P. N.; Clark, J. I.; Flanigan, R. C.; Picken, M. M., American Journal of Clinical Pathology
- Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells. Basrawala, Z.; Alimirah, F.; Xin, H.; Mohideen, N.; Campbell, S. C.; Flanigan, R. C.; Choubey, D., Oncogene
- Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning. Venkataraman, G.; Ananthanarayanan, V.; Paner, G. P.; He, R.; Masoom, S.; Sinacore, J.; Flanigan, R. C.; Wojcik, E. M., Virchows Archiv
- Radical cystectomy with extended lymphadenectomy in the presence of a pelvic kidney. Quek, M. L.; Basrawala, Z.; McClung, C.; Flanigan, R. C., Urology
- Subspecialty certification in urology: a US perspective. Flanigan, R. C., Nature Clinical Practice Urology
- The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma. Denberg, T. D.; Kim, F. J.; Flanigan, R. C.; Fairclough, D.; Beaty, B. L.; Steiner, J. F.; Hoffman, R. M., Medical care
- The relationship between threat appraisal and social constraints in cancer survivors and their spouses. Herzer, M.; Zakowski, S. G.; Flanigan, R. C.; Johnson, P., Journal of Behavioral Medicine
- Urothelial-cell carcinoma and solitary kidney: outcomes with renal-sparing management. Milner, J. E.; Voelzke, B. B.; Flanigan, R. C.; Sharma, S. K.; Perry, K. T.; Turk, T. M., Journal of Endourology
- Utility of prostate biopsy morphometric sum optical density for identifying extraprostatic extension on subsequent prostatectomy. Bargaje, A.; Venkataraman, G.; Flanigan, R. C.; Wojcik, E. M.; Ananthanarayanan, V., Analytical & Quantitative Cytology & Histology
- A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109 Van Veldhuizen, P. J.; Faulkner, J. R.; Lara, P. N., Jr; Gumerlock, P. H.; Goodwin, J. W.; Dakhil, S. R.; Gross, H. M.; Flanigan, R. C.; Crawford, E. D.; Southwest Oncology Group, CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Does lymphadenectomy improve cancer-specific survival in patients with renal cell carcinoma?. Flanigan, R. C., Nature Clinical Practice Urology
- Renal neoplasms in younger adults: analysis of 112 tumors from a single institution according to the new 2004 World Health Organization classification and 2002 American Joint Committee on Cancer Staging System. Cao, Y.; Paner, G. P.; Perry, K. T.; Flanigan, R. C.; Campbell, S. C.; Picken, M. M., Archives of Pathology & Laboratory Medicine
- Risk assessment for occult malignancy in the prostate before radical cystectomy. Kefer, J. C.; Voelzke, B. B.; Flanigan, R. C.; Wojcik, E. M.; Waters, W. B.; Campbell, S. C., Urology
- The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. Mulhall, J.; Land, S.; Parker, M.; Waters, W. B.; Flanigan, R. C., Journal of Sexual Medicine
- The utility of screening renal ultrasonography: identifying renal cell carcinoma in an elderly asymptomatic population. Malaeb, B. S.; Martin, D. J.; Littooy, F. N.; Lotan, Y.; Waters, W. B.; Flanigan, R. C.; Koeneman, K. S., BJU international
- Cytogenetic analysis of a series of 13 renal oncocytomas. Lindgren, V.; Paner, G. P.; Omeroglu, A.; Campbell, S. C.; Waters, W. B.; Flanigan, R. C.; Picken, M. M., Journal of Urology
- Cytologic features of recurrent lymphoma involving the urinary bladder. Quinn, A. M.; Flanigan, R. C.; Sienko, A.; Wojcik, E. M., Diagnostic cytopathology
- Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis Flanigan, R. C.; Mickisch, G.; Sylvester, R.; Tangen, C.; Van Poppel, H.; Crawford, E. D., Journal of Urology
- Debulking nephrectomy in metastatic renal cancer Flanigan, R. C., Clinical Cancer Research
- Innovations and challenges in renal cancer: consensus statement from the first international conference Atkins, M. B.; Avigan, D. E.; Bukowski, R. M.; Childs, R. W.; Dutcher, J. P.; Eisen, T. G.; Figlin, R. A.; Finke, J. H.; Flanigan, R. C.; George, D. J.; Goldberg, S. N.; Gordon, M. S.; Iliopoulos, O.; Kaelin, W. G., Jr; Linehan, W. M.; Lipton, A.; Motzer, R. J.; Novick, A. C.; Stadler, W. M.; Teh, B. T.; Yang, J. C.; King, L., Clinical Cancer Research
- Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma. Freeman, V. L.; Meydani, M.; Hur, K.; Flanigan, R. C., Cancer
- Metastatic juxtaglomerular cell tumor in a 52-year-old man. Duan, X.; Bruneval, P.; Hammadeh, R.; Fresco, R.; Eble, J. N.; Clark, J. I.; Vigneswaran, W. T.; Flanigan, R. C.; Picken, M. M., American Journal of Surgical Pathology
- Pathologic quiz case: renal mass in an otherwise healthy man. Epithelioid angiomyolipoma. Rubinas, T. C.; Flanigan, R. C.; Picken, M. M., Archives of Pathology & Laboratory Medicine
- Renal tumor with overlapping distal nephron morphology and karyotype. Lindgren, V.; Paner, G. P.; Flanigan, R. C.; Clark, J. I.; Campbell, S. C.; Picken, M. M., Archives of Pathology & Laboratory Medicine
- Renal tumors in young adults Eggener, S. E.; Rubenstein, J. N.; Smith, N. D.; Nadler, R. B.; Kontak, J.; Flanigan, R. C.; Waters, W. B.; Picken, M.; Campbell, S. C., Journal of Urology
- The prevalence and nature of orgasmic dysfunction after radical prostatectomy. Barnas, J. L.; Pierpaoli, S.; Ladd, P.; Valenzuela, R.; Aviv, N.; Parker, M.; Waters, W. B.; Flanigan, R. C.; Mulhall, J. P., BJU international
- Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Zakowski, S. G.; Ramati, A.; Morton, C.; Johnson, P.; Flanigan, R. C., Health Psychology
- Cytoreductive nephrectomy in metastatic renal cancer Flanigan, R. C., Current urology reports
- Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture. Unger, J. M.; LeBlanc, M.; Crowley, J. J.; Grossman, H. B.; Natale, R. B.; Wozniak, A. J.; Berenson, J. R.; List, A. F.; Peters, W. A., 3rd; Flanigan, R. C.; Macdonald, J. S.; Al-Sarraf, M.; Thompson, I. M.; Coltman, C. A., Jr, Journal of Clinical Oncology
- Heat Shock Proteins: Biology and Potential Clinical Application. Flanigan, R. C., Kidney Cancer
- Metastatic renal cell carcinoma Flanigan, R. C.; Campbell, S. C.; Clark, J. I.; Picken, M. M., Current Treatment Options in Oncology
- Nephrectomy in metastatic renal cell carcinoma Campbell, S. C.; Flanigan, R. C.; Clark, J. I., Current Treatment Options in Oncology
- Radical retropubic prostatectomy - what works for me Flanigan, R. C., Contemporary Urology
- Role of nephrectomy in metastatic kidney cancer Yonover, P. M.; Sharma, S. K.; Flanigan, R. C., Cancer Treatment & Research
- Social barriers to emotional expression and their relations to distress in male and female cancer patients. Zakowski, S. G.; Harris, C.; Krueger, N.; Laubmeier, K. K.; Garrett, S.; Flanigan, R. C.; Johnson, P., British Journal of Health Psychology
- Effect of prostatic edema on CT-based postimplant dosimetry. Dogan, N.; Mohideen, N.; Glasgow, G. P.; Keys, K.; Flanigan, R. C., International journal of radiation oncology, biology, physics
- Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. Mulhall, J. P.; Slovick, R.; Hotaling, J.; Aviv, N.; Valenzuela, R.; Waters, W. B.; Flanigan, R. C., Journal of Urology
- Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study. Whitehead, R. P.; Lew, D.; Flanigan, R. C.; Weiss, G. R.; Roy, V.; Glode, M. L.; Dakhil, S. R.; Crawford, E. D., Journal of Immunotherapy
- Role of nephrectomy in metastatic renal cell carcinoma. Flanigan, R. C.; Yonover, P. M.; Campbell, S. C., AUA Update Series
- Survival advantage of Interleukin-2 over Interferon Immunotherapy when combine with cytoreductive nephrectomy based on SWOP 8949-matched populations. Pantuck, A. J.; Zisman, A.; Chao, D.; Dorey, F.; Flanigan, R. C.; DeKernion, J. B.; Figlin, R.; Belldegrun, A., Journal of Urology
- The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomy. Gatenby, R. A.; Gawlinski, E. T.; Tangen, C. M.; Flanigan, R. C.; Crawford, E. D., Cancer research
- Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice. Ellis, T. M.; Moser, M. T.; Le, P. T.; Flanigan, R. C.; Kwon, E. D., International immunology
- Assessing the effect of fatty acids on prostate carcinogenesis in humans: does self-reported dietary intake rank prostatic exposure correctly?. Freeman, V. L.; Meydani, M.; Yong, S.; Pyle, J.; Durazo-Arvizu, R. A.; Liao, Y.; Flanigan, R. C.; Waters, W. B., American Journal of Clinical Nutrition
- Is a 1-CM margin necessary during nephron-sparing surgery for renal cell carcinoma?. Piper, N. Y.; Bishoff, J. T.; Magee, C.; Haffron, J. M.; Flanigan, R. C.; Mintiens, A.; Van Poppel, H. P.; Thompson, I. M.; Harmon, W. J., Urology
- Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. Flanigan, R. C.; Salmon, S. E.; Blumenstein, B. A.; Bearman, S. I.; Roy, V.; McGrath, P. C.; Caton, J. R., Jr; Munshi, N.; Crawford, E. D., New England Journal of Medicine
- Phase II evaluation of suramin in advanced renal cell carcinoma. A Southwest Oncology Group study Schroder, L. E.; Lew, D.; Flanigan, R. C.; Eisenberger, M. A.; Seay, T. E.; Hammond, N.; Needles, B. M.; Crawford, E. D., Urologic oncology
- T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer. Mercader, M.; Bodner, B. K.; Moser, M. T.; Kwon, P. S.; Park, E. S.; Manecke, R. G.; Ellis, T. M.; Wojcik, E. M.; Yang, D.; Flanigan, R. C.; Waters, W. B.; Kast, W. M.; Kwon, E. D., Proceedings of the National Academy of Sciences of the United States of America
- The role of radical nephrectomy in metastatic renal cell carcinoma Flanigan, R. C.; Yonover, P. M., Seminars in urologic oncology
- The role of resection for patients with renal carcinoma Flanigan, R. C.; Yonover, P. M., Current oncology reports
- Bacillus Calmette-Guerin. Is monthly maintenance an option for transitional cell carcinoma of the bladder? Flanigan, R. C.; DeLaurentis, D. A.; Waters, W. B.; Kunz, K., Urologic oncology
- Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases. Bakhos, R.; Shankey, T. V.; Flanigan, R. C.; Fisher, S.; Wojcik, E. M., Diagnostic cytopathology
- Comparison of percent free PSA PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging., Catalona, W. J.; Southwick, P. C.; Slawin, K. M.; Partin, A. W.; Brawer, M. K.; Flanigan, R. C.; Patel, A.; Richie, J. P.; Walsh, P. C.; Scardino, P. T.; Lange, P. H.; Gasior, G. H.; Loveland, K. G.; Bray, K. R., Urology
- Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study Elias, L.; Lew, D.; Figlin, R. A.; Flanigan, R. C.; Thompson, M. E.; Triozzi, P. L.; Belt, R. J.; Wood, D. P., Jr; Rivkin, S. E.; David, E., Cancer
- Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial. Catalona, W. J.; Partin, A. W.; Slawin, K. M.; Naughton, C. K.; Brawer, M. K.; Flanigan, R. C.; Richie, J. P.; Patel, A.; Walsh, P. C.; Scardino, P. T.; Lange, P. H.; deKernion, J. B.; Southwick, P. C.; Loveland, K. G.; Parson, R. E.; Gasior, G. H., Urology
- Primary localized amyloidosis of the ureter and bladder managed by ileal interposition. Hafron, J. M.; Flanigan, R. C., Techniques in urology
- Prostatic levels of fatty acids and the histopathology of localized prostate cancer. Freeman, V. L.; Meydani, M.; Yong, S.; Pyle, J.; Flanigan, R. C.; Waters, W. B.; Wojcik, E. M., Journal of Urology
- Renal cell carcinoma with metastasis to the thyroid gland Pitale, S. U.; Sizemore, G. W.; Bakhos, R.; DeJong, S. A.; Flanigan, R. C.; Emanuele, N. V., Urologic oncology
- Should radical nephrectomy be performed in the face of surgically incurable disease? Yonover, P. M.; Flanigan, R. C., Current opinion in urology
- The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection. Gao, X.; Mohideen, N.; Flanigan, R. C.; Waters, W. B.; Wojcik, E. M.; Leman, C. R., Journal of Urology
